Sir David Lane
Director, p53 Laboratory
Sir David Lane is credited with the landmark discovery of p53 and its role in cancer development. As the Chief Scientist of A*STAR, Lane advises and engages in scientific development across the Biomedical Research Council (BMRC) and the Scientific Engineering Research Council (SERC) at the strategic level. Lane is concurrently the Director of the p53 Laboratory, which primarily focuses on research on protein interactions and how to develop drugs to inhibit such interactions, using p53 as a model system.
Sweet serendipity unveils anticancer strategy29 Nov 2019
A better understanding of the way sugar units are attached to the surface proteins of
A stabilizing strategy to keep cancer cells in check29 Nov 2019
Bortezomib, a drug that inhibits the ‘waste disposal system’ in animal cells, could be used